Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications hifmech study group plasma fibrinogen concentration predicts risk myocardial infarction
Thirteenth Annual FDA Sentinel Initiative Public Workshop Share on: Monday, November 8, 2021, 10am - Tuesday, November 9, 2021, 2pm Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …
… and administer the survey: We recruit subjects for each study that are representative of the target patient … data and provide reports and manuscripts : We provide study reports, manuscripts for peer-reviewed journals , and …
… involve White participants, making up 80% to 90% of the study groups. This demographic disparity raises significant … Without including diverse populations in clinical trials, study sponsors struggle to ensure the effectiveness of … information on disease understanding, associated risk factors, and demographic prevalence and incidence of the …
… Randomization Interim and final data analyses Clinical Study Reports (CSR) Support for regulatory agency submissions … if patient-reported QoL data was not collected in your study, we can apply the Q-TWiST method to quantitatively assess the benefit/risk tradeoff of your new treatment regimen. Healthcare …
Economic Qualitative Inquiry, Policy, and Access Our focused research will enable you to demonstrate your products’ value to patients, physicians, caregivers, payers, and policymakers. With so many public, private, and non-traditional payers and their …
2023 Italian Society of Hygiene, Preventive Medicine, and Public Health (SITI) Conference Share on: Thursday, October 12 - Saturday, October 14, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 …
… Part D and Part B combined of less than $200 million Plasma-derived products Small biotech drugs (2026-2028) … and the public may submit such data. CMS will likely group questions into the following categories: Manufacturer … the evidence, CMS will consider: Source Rigor of the study methodology Current relevance to the selected drug and …
… including regulatory submissions, reports, and publications Support to secure regulatory acceptability of …
Market Access and Outcomes Strategy You need the right strategies and tactics to reflect your product’s value and gain market access. And when millions—or maybe billions—are on the line, you have to be confident that your strategies are well-researched …